Market Place
Sourcing Support
GSK to cap out-of-pocket inhaler costs in US
21 Mar 2024 //
REUTERS
Drugmakers benefit `substantially` from secondary patents on inhalers — study
03 Jan 2023 //
ENDPTS
Enforcement Report- Week of October 27, 2021
27 Oct 2021 //
FDA
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®
21 Sep 2020 //
BLOOMBERG
Cipla submits application with USFDA for generic version of asthma drug
18 May 2020 //
ECONOMICTIMES
Cipla share price up 8% on successful completion of Ph-3 study of asthma drug
02 Apr 2020 //
MONEYCONTROL
Teva announces FDA approval of ArmonAir Digihaler inhalation powder
24 Feb 2020 //
NJBIZ
GSK leans on respiratory franchise with Trelegy share-grab
30 Oct 2019 //
FIERCE PHARMA
FDA knocks back AstraZeneca`s respiratory ambitions
02 Oct 2019 //
BIOPHARMADIVE
Charging at blockbuster Advair, Novartis boasts topline victories
30 Sep 2019 //
ENDPTS
Product Hopping: E&C Hearing Addresses Restrictions to Generic Competition
19 Sep 2019 //
RAPS
New respiratory drugs, Shingrix help GSK weather Advair generics
25 Jul 2019 //
FIERCE PHARMA
AstraZeneca’s COPD triplet Breztri nabs first nod from Japan
20 Jun 2019 //
FIERCE PHARMA
GSK pharma head flags need for speed in high-pressure drug market
17 Jun 2019 //
REUTERS
Novartis` asthma triplet beats GSK`s Advair in phase 2 trial
23 May 2019 //
FIERCE BIOTECH
Mylan investors are fed up with management, analysts say
09 May 2019 //
FIERCE PHARMA
Generic Advair hits GSK revenues hard
01 May 2019 //
BIOPHARMADIVE
Biotech shares continue to fall on FDA uncertainty
08 Mar 2019 //
CNBC
Mylan`s Advair generic pressures GSK with strong launch
08 Mar 2019 //
BIOPHARMADIVE
Mylan shares sink as bleak profit outlook sparks growth concerns
28 Feb 2019 //
CNBC
UBS strips GSK of ‘buy’ recommendation on fears for its ViiV HIV division
23 Feb 2019 //
PROACTIVE INVESTOR
Mylan`s generic Advair discount not as big as it looks: analysts
14 Feb 2019 //
FIERCE PHARMA
FDA draft lays out submission paths for combo products
07 Feb 2019 //
MEDTECH DRIVE
Hal Barron’s GSK team continues to cull resp drugs in big shift to oncology R&D
06 Feb 2019 //
ENDPTS
Mylan Wins FDA Approval for First Advair Generic
01 Feb 2019 //
RAPS
FDA approves first generic Advair Diskus
31 Jan 2019 //
FDA
GSK about to see Mylan’s generic carve into its mega-blockbuster Advair franchise
31 Jan 2019 //
ENDPTS
Vectura sinks after PhIII asthma trial ends in failure, marking another setback
26 Nov 2018 //
ENDPTS
That generic Advair you`ve been expecting for months? It`ll come, Mylan says
07 Nov 2018 //
FIERCE PHARMA
Mylan`s Beat Lifts Hopes That Worst Is Over for Generic Drugs
06 Nov 2018 //
BLOOMBERG
GlaxoSmithKline expands API production for COPD inhalers
24 Oct 2018 //
FIERCE PHARMA
Mylan reveals its $463M mystery buy - Novartis` TOBI cystic fibrosis products
07 Sep 2018 //
FIERCE PHARMA
AZ rival to GSK’s COPD drug Anoro fails head-to-head test
24 Aug 2018 //
PMLIVE
Hit by surprise setback, AZ explains why inhaler beaten by GSK rival
23 Aug 2018 //
ENDPTS
GSK chief rounds out her top team with CFO pick — but performance lags
08 Aug 2018 //
ENDPTS
Drugs for heart failure are still under-prescribed, years after initial study
02 Aug 2018 //
SCIENCE DAILY
What`s in the Cards for Glaxo This Earnings Season?
24 Jul 2018 //
NASDAQ
Mylan preps for rejection of Advair copy
15 Jun 2018 //
REUTERS
UPDATE 2-FDA finds deficiencies in Mylan`s generic Advair; shares fall
13 Jun 2018 //
CNBC
Mylan CEO`s EpiPen defense reverberates in pricing debate
04 Jun 2018 //
FIERCE PHARMA
Glaxo`s Advair Is the $100 Billion Asthma Drug That Won`t Die
03 May 2018 //
BLOOMBERG
GSK pharma boss rejigs operations to double down on launches
22 Mar 2018 //
FIERCE PHARMA
New Hikma CEO Olafsson gets to work on 200 more generics layoffs
17 Mar 2018 //
FIERCE PHARMA
FDA sends Hikma back to the clinic with generic Advair
14 Mar 2018 //
FIERCE PHARMA
GSK escapes Advair hit for now as second generic bid fails
13 Mar 2018 //
REUTERS
Novartis` Advair copy stiff-armed at FDA, giving GSK a reprieve
09 Feb 2018 //
FIERE PHARMA
GlaxoSmithKline sees light at end of Advair tunnel
08 Feb 2018 //
REUTERS
The decade`s top 10 patent losses, worth a whopping $915B in lifetime sales
17 Aug 2017 //
FIERCE PHARMA
Hikma Pharma trims guidance as generic Advair talks continue with FDA
16 Aug 2017 //
SHARE CAST
Mylan points finger at FDA for missing Advair, Copaxone copies
10 Aug 2017 //
FIERCE PHARMA
Valeant prices psoriasis treatment at $3,500 per month (April 21)
28 Apr 2017 //
REUTER
6 Biotechs Facing Key FDA Decisions in March
27 Feb 2017 //
BIOSPACE
Federal Judge Blocks Anthem’s Planned Acquisition of Cigna
10 Feb 2017 //
WALL STREET JOURNAL
GSK books solid results on weak pound, new products
09 Feb 2017 //
PHARMATIMES
How does GSK`s incoming chief view the Advair generic threat?
06 Feb 2017 //
FIERCE PHARMA
Bernie Sanders: Will Trump have the guts to stand up to drug companies?
03 Feb 2017 //
WASHINGTON POST
AirDuo steps up to challenge Advair, but the newcomer`s fate depends on price
01 Feb 2017 //
FIERCE PHARMA
FDA Approves Two Teva Asthma Treatments
31 Jan 2017 //
GLOBES
Cipla gets UK nod to sell key inhaler for asthmatics
27 Dec 2016 //
BUSINESS STANDARD
Orion seeks EU market authorisation for asthma/COPD product
23 Dec 2016 //
EUROPEAN PHARMACEUTICAL
